They work on different but complementary pathways, with glutathione providing foundational antioxidant support and azelaic acid targeting specific concerns like pigmentation and inflammation
2) is widely accepted, and several inducers of this type of erythrocyte death have been described, including the antiinflammatory compounds Bay 11-7082, parthenolide, and dimethyl fumarate [113], H 2 O 2 [114], the food additive E407a (semi-refined carrageenan) [115], and the tricyclic antidepressant desipramine [116]
Both substances affect GABAergic systems, and combining them may produce unpredictable sedation
Possible (usually mild) side effects may include: Temporary discomfort or bruising at the injection site Mild headache or nausea in some individuals Rare irritation of the vein (phlebitis) Very rare allergic reactions (screened during pre-treatment assessment) Guided by international clinical standards (Cleveland Clinic, NHS protocols) Serious complications are uncommon when IV infusion therapy is delivered in a controlled clinical setting with appropriate patient selection and monitoring
Takemura K, Board PG, Koga F
PMID 9503014